Cipla - Quaterly Results

04 Nov 2022 Evaluate
A fair growth of 8.57% in the revenue at Rs. 41512.70 millions was reported in the September 2022 quarter as compared to Rs. 38234.50 millions during year-ago period.Net profit declined -7.93% to Rs. 7051.90 millions from Rs. 7659.50 millions.The company reported a degrowth in operating Profit to 11533.30 millions from 11586.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 41512.70 38234.50 8.57 73084.00 73341.20 -0.35 130917.90 113027.10 15.83
Other Income 922.80 1977.30 -53.33 2099.60 2773.90 -24.31 6667.00 2302.80 189.52
PBIDT 11533.30 11586.10 -0.46 21283.90 23563.90 -9.68 40331.70 32976.90 22.30
Interest 75.00 76.00 -1.32 97.10 156.00 -37.76 269.30 450.70 -40.25
PBDT 11458.30 11510.10 -0.45 21186.80 23407.90 -9.49 40062.40 32526.20 23.17
Depreciation 1760.10 1389.70 26.65 2834.70 2529.40 12.07 4600.10 4686.20 -1.84
PBT 9698.20 10120.40 -4.17 18352.10 20878.50 -12.10 35462.30 27840.00 27.38
TAX 2646.30 2460.90 7.53 4860.20 5333.90 -8.88 8568.40 7393.50 15.89
Deferred Tax -6.00 30.20 -119.87 -118.50 -59.10 100.51 -304.00 -169.20 79.67
PAT 7051.90 7659.50 -7.93 13491.90 15544.60 -13.21 26893.90 20446.50 31.53
Equity 1614.00 1613.30 0.04 1614.00 1613.30 0.04 1613.60 1612.90 0.04
PBIDTM(%) 27.78 30.30 -8.32 29.12 32.13 -9.36 30.81 29.18 5.59

Cipla Share Price

1491.40 -3.00 (-0.20%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×